- Home
- ABEO vs SFST Comparison
ABEO vs SFST Comparison
Compare ABEO & SFST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ABEO
- SFST
- Stock Information
- Founded
- ABEO N/A
- SFST 1999
- Country
- ABEO United States
- SFST United States
- Employees
- ABEO N/A
- SFST N/A
- Industry
- ABEO Biotechnology: Pharmaceutical Preparations
- SFST Major Banks
- Sector
- ABEO Health Care
- SFST Finance
- Exchange
- ABEO Nasdaq
- SFST Nasdaq
- Market Cap
- ABEO 247.8M
- SFST 344.3M
- IPO Year
- ABEO 1980
- SFST 1999
- Fundamental
- Price
- ABEO $5.70
- SFST $40.65
- Analyst Decision
- ABEO Strong Buy
- SFST Buy
- Analyst Count
- ABEO 3
- SFST 1
- Target Price
- ABEO $18.00
- SFST $44.00
- AVG Volume (30 Days)
- ABEO 229.2K
- SFST 21.9K
- Earning Date
- ABEO 11-14-2024
- SFST 01-16-2025
- Dividend Yield
- ABEO N/A
- SFST N/A
- EPS Growth
- ABEO N/A
- SFST N/A
- EPS
- ABEO N/A
- SFST 1.73
- Revenue
- ABEO N/A
- SFST $90,166,000.00
- Revenue This Year
- ABEO N/A
- SFST N/A
- Revenue Next Year
- ABEO $18,714.71
- SFST $13.55
- P/E Ratio
- ABEO N/A
- SFST $23.50
- Revenue Growth
- ABEO 147.52
- SFST 3.18
- 52 Week Low
- ABEO $3.05
- SFST $24.98
- 52 Week High
- ABEO $9.01
- SFST $45.91
- Technical
- Relative Strength Index (RSI)
- ABEO 34.30
- SFST 43.15
- Support Level
- ABEO $5.45
- SFST $39.47
- Resistance Level
- ABEO $6.04
- SFST $42.99
- Average True Range (ATR)
- ABEO 0.19
- SFST 1.30
- MACD
- ABEO -0.04
- SFST -0.58
- Stochastic Oscillator
- ABEO 19.47
- SFST 26.34
About ABEO Abeona Therapeutics Inc.
Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases. Its clinical programs consist of pz-cel, an autologous, engineered cell therapy currently in development for recessive dystrophic epidermolysis bullosa (RDEB). The Company's development portfolio also features adeno-associated virus (AAV)-based gene therapies designed to treat unmet, medically needed ophthalmic diseases using the novel AIM.
About SFST Southern First Bancshares Inc.
Southern First Bancshares Inc is a bank holding company. The company engaged in the business of accepting demand deposits and savings deposits insured by the Federal Deposit Insurance Corporation (the "FDIC"), and providing commercial, consumer and mortgage loans to the general public of which a majority of the revenue is derived from the Commercial and Retail Banking segment which includes the provision of traditional deposit and lending products and services to its commercial and retail banking clients.